Scott S. Lee

Dr. Scott S. Lee

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in Journal of Economic Behavior & Organization
Verified
Journal Article
Open access
NANava Ashraf
Nava Ashraf
OBOriana Bandiera
Oriana Bandiera
SLScott S. Lee
Scott S. Lee
Organizations often use non-monetary awards to incentivize performance. Awards may affect behavior through several mechanisms: by conferring employer recognition, by enhancing social visibility, and by facilitating social comparison. In a nationwide health worker training program in Zambia, we design a field experiment to unbundle these mechanisms. We find that employer recognition and social visibility increase performance while social comparison reduces it, especially for low-ability trainees. These effects appear when treatments are announced and persist through training. The findings are consistent with a model of optimal expectations in which low-ability individuals exert low effort in order to avoid information about their relative ability

1 September 2022 in Health Psychology
Verified
Journal Article
Closed access
NSNicole Senft
Nicole Senft
WKWilliam M. P. Klein
William M. P. Klein
SLScott S. Lee
Scott S. Lee
RSRebecca Selove
Rebecca Selove
MSMaureen Sanderson
Maureen Sanderson
HTHilary A. Tindle
Hilary A. Tindle
To test whether 2 conceptually overlapping constructs, dispositional optimism (generalized positive expectations) and optimistic bias (inaccurately low risk perceptions), may have different implications for smoking treatment engagement. Predominantly Black, low-income Southern Community Cohort study smokers (n = 880) self-reported dispositional optimism and pessimism (Life Orientation Test-Revised subscales: 0 = neutral, 12 = high optimism/pessimism), comparative lung cancer risk (Low/Average/High), and information to calculate objective lung cancer risk (Low/Med/High). Perceived risk was categorized as accurate (perceived = objective), optimistically-biased (perceived < objective), or pessimistically-biased (perceived > objective). One-way ANOVAs tested associations between dispositional optimism/pessimism and perceived risk accuracy. Multivariable logistic regressions tested independent associations of optimism/pessimism and perceived risk accuracy with cessation motivation (Low/High), confidence (Low/High), and precision treatment attitudes (Favorable/Unfavorable), controlling for sociodemographics and nicotine dependence. Mean dispositional optimism/pessimism scores were 8.41 (SD = 2.59) and 5.65 (SD = 3.02), respectively. Perceived lung cancer risk was 38% accurate, 27% optimistically-biased, and 35% pessimistically-biased. Accuracy was unrelated to dispositional optimism (F(2, 641) = 1.23, p = .29), though optimistically-biased (vs. pessimistically-biased) smokers had higher dispositional pessimism (F(2, 628) = 3.17, p = .043). Dispositional optimism was associated with higher confidence (Adjusted odds ratio [AOR] = 1.71, 95% CI [1.42, 2.06], p < .001) and favorable precision treatment attitudes (AOR = 1.66, 95% CI [1.37, 2.01], p < .001). Optimistically-biased (vs. accurate) risk perception was associated with lower motivation (AOR = .64, 95% CI [.42, .98], p = .041) and less favorable precision treatment attitudes (AOR = .59, 95% CI [.38, .94], p = .029). Dispositional optimism and lung cancer risk perception accuracy were unrelated. Dispositional optimism was associated with favorable engagement-related outcomes and optimistically-biased risk perception with unfavorable outcomes, reinforcing the distinctiveness of these constructs and their implications for smoking treatment. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

20 May 2023 in Nicotine & Tobacco Research
Verified
Journal Article
Closed access
PDF file
SLScott S. Lee
Scott S. Lee
YCYuchiao Chang
Yuchiao Chang
NRNancy A Rigotti
Nancy A Rigotti
DSDaniel E Singer
Daniel E Singer
DLDouglas Levy
Douglas Levy
HTHilary A Tindle
Hilary A Tindle
Introduction: The nicotine metabolite ratio (NMR), a biomarker of CYP2A6-mediated nicotine metabolism, predicts the efficacy of nicotine replacement therapy (NRT), with fast metabolizers benefiting less than slow metabolizers. Whether treatment support to optimize NRT use (henceforth “treatment support”) modifies this pharmacogenetic relationship is unknown. Methods: Hospitalized adult daily smokers were assigned to one of two post-discharge smoking cessation interventions offering NRT and counseling: (1) Transitional Tobacco Care Management, which delivered enhanced treatment support via free combination NRT at discharge and automated counseling, and (2) a quitline-based approach representing usual care (UC). The primary outcome was biochemically verified 7-day point prevalence abstinence 6 months after discharge. Secondary outcomes were the use of NRT and counseling during the 3-month intervention period. Logistic regression models tested for interactions between NMR and intervention, controlling for sex, race, alcohol use, and BMI. Results: Participants (N = 321) were classified as slow (n = 80) or fast (n = 241) metabolizers relative to the first quartile of NMR (0.012–0.219 vs. 0.221–3.455, respectively). Under UC, fast (vs. slow) metabolizers had lower odds of abstinence at 6 months (aOR 0.35, 95% CI 0.13–0.95) and similar odds of NRT and counseling use. Compared to UC, enhanced treatment support increased abstinence (aOR 2.13, 95% CI 0.98–4.64) and use of combination NRT (aOR 4.62, 95% CI 2.57–8.31) in fast metabolizers, while reducing abstinence in slow metabolizers (aOR 0.21, 95% CI 0.05–0.87; NMR-by-intervention interaction p = .004). Conclusions: Treatment support increased abstinence and optimal use of NRT among fast nicotine metabolizers, thereby mitigating the gap in abstinence between fast and slow metabolizers. Implications: In this secondary analysis of two smoking cessation interventions for recently hospitalized smokers, fast nicotine metabolizers quit at lower rates than slow metabolizers, but providing fast metabolizers with enhanced treatment support doubled the odds of quitting in this group and mitigated the disparity in abstinence between fast and slow metabolizers. If validated, these findings could lead to personalized approaches to smoking cessation treatment that improve outcomes by targeting treatment support to those who need it most.

15 March 2024 in Addiction Science & Clinical Practice
Verified
Journal Article
Open access
PDF file
SLScott S. Lee
Scott S. Lee
NENicole Senft Everson
Nicole Senft Everson
MSMaureen Sanderson
Maureen Sanderson
RSRebecca Selove
Rebecca Selove
WBWilliam J. Blot
William J. Blot
HTHilary A. Tindle
Hilary A. Tindle
Background: The feasibility of precision smoking treatment in socioeconomically disadvantaged communities has not been studied. Methods: Participants in the Southern Community Cohort Study who smoked daily were invited to join a pilot randomized controlled trial of three smoking cessation interventions: guideline-based care (GBC), GBC plus nicotine metabolism-informed care (MIC), and GBC plus counseling guided by a polygenic risk score (PRS) for lung cancer. Feasibility was assessed by rates of study enrollment, engagement, and retention, targeting > 70% for each. Using logistic regression, we also assessed whether feasibility varied by age, sex, race, income, education, and attitudes toward precision smoking treatment. Results: Of 92 eligible individuals (79.3% Black; 68.2% with household income < $15,000), 67 (72.8%; 95% CI 63.0–80.9%) enrolled and were randomized. Of these, 58 (86.6%; 95% CI 76.4–92.8%) engaged with the intervention, and of these engaged participants, 43 (74.1%; 95% CI 61.6–83.7%) were retained at 6-month follow-up. Conditional on enrollment, older age was associated with lower engagement (OR 0.83, 95% CI 0.73–0.95, p = 0.008). Conditional on engagement, retention was significantly lower in the PRS arm than in the GBC arm (OR 0.18, 95% CI 0.03–1.00, p = 0.050). No other selection effects were observed. Conclusions: Genetically informed precision smoking cessation interventions are feasible in socioeconomically disadvantaged communities, exhibiting high enrollment, engagement, and retention irrespective of race, sex, income, education, or attitudes toward precision smoking treatment. Future smoking cessation interventions in this population should take steps to engage older people and to sustain participation in interventions that include genetic risk counseling. Trial registration: ClinicalTrials.gov No. NCT03521141, Registered 27 April 2018, https://www.clinicaltrials.gov/study/NCT03521141

20 May 2023 in American Journal of Preventive Medicine
Verified
Journal Article
Closed access
EBEden Y. Bernstein
Eden Y. Bernstein
YCYuchiao Chang
Yuchiao Chang
DLDouglas Levy
Douglas Levy
TBTravis P. Baggett
Travis P. Baggett
SLScott S. Lee
Scott S. Lee
NRNancy A. Rigotti
Nancy A. Rigotti

5 January 2018 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
SLScott S. Lee
Scott S. Lee
Although extrinsic and intrinsic motivation likely jointly explain the effort of many agents engaged in public service delivery, canonical models of incentives in firms focus on the former. In the context of a rural health worker program in India, I develop and test a novel mobile phone app designed to increase agents’ intrinsic returns to effort. At one year of follow-up, the self-tracking app leads to a 24% increase in performance as measured by the main job task (home visits). Moreover, the app is most effective when it leverages pre-existing intrinsic motivation: it produces a 41% increase in performance in the top tercile of intrinsically motivated workers, but no improvement in the bottom tercile. This treatment effect persists over time for the most intrinsically motivated workers, whereas early improvements decay among the least motivated workers. Supplementary evidence suggests that the treatment effect on performance is mediated primarily by making effort more intrinsically rewarding, and not by other mechanisms such as the provision of implicit extrinsic incentives. Despite these effects on worker performance, I find no effect on health outcomes.